Peer Review History
| Original SubmissionNovember 5, 2025 |
|---|
|
Dear Robert, Thank you for submitting your manuscript entitled "Macrophage chemotaxis steered by complex self-generated gradients of complement C5a" for consideration as a Research Article by PLOS Biology. Your manuscript has now been evaluated by the PLOS Biology editorial staff as well as by an academic editor with relevant expertise and I am writing to let you know that we would like to send your submission out for external peer review. However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire. Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. After your manuscript has passed the checks it will be sent out for review. To provide the metadata for your submission, please Login to Editorial Manager (https://www.editorialmanager.com/pbiology) within two working days, i.e. by Nov 24 2025 11:59PM. During the process of completing your manuscript submission, you will be invited to opt-in to posting your pre-review manuscript as a bioRxiv preprint. Visit http://journals.plos.org/plosbiology/s/preprints for full details. If you consent to posting your current manuscript as a preprint, please upload a single Preprint PDF. Feel free to email us at plosbiology@plos.org if you have any queries relating to your submission. Kind regards, Ines -- Ines Alvarez-Garcia, PhD Senior Editor PLOS Biology ialvarez-garcia@plos.org |
| Revision 1 |
|
Dear Robert, Thank you for your patience while your manuscript entitled "Macrophage chemotaxis steered by complex self-generated gradients of complement C5a" was peer-reviewed at PLOS Biology. The manuscript has now been evaluated by the PLOS Biology editors, an Academic Editor with relevant expertise, and by two independent reviewers. The reviews are attached below. As you will see, the reviewers find the conclusions interesting and worth pursuing, but they also raise a few issues that would need to be addressed before we can consider the manuscript for publication. Reviewer 1 notes that the model used for some initial results was not applied elsewhere in the paper, and that it could be useful to simulate other results. This reviewer also thinks that the ‘wave of cell migration’ described should be quantified along with the response to an initial gradient of C5a, and that it would be interesting to try to change the initial cell densities and measure responses, as well as simulating the experiments with the model. If some of these experiments are too challenging, please discuss the pertinent points and limitations in the text. Reviewer 2 mainly requests the discussion of several points, including why THP-1 cells are used rather than human peripheral blood monocyte-derived macrophages, the differences in actin cytoskeletal dynamics in mouse BMDMs vs THP-1 cells, and the potential roles of relay signals. In light of the reviews and discussion with the Academic Editor and the rest of the team, we would like to invite you to revise the work to thoroughly address the reviewers' reports. Given the revision needed, we cannot make a decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is likely to be sent for further evaluation by all or a subset of the reviewers. In addition to these revisions, you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests shortly. We expect to receive your revised manuscript within 3 months. Please email us (plosbiology@plos.org) if you have any questions or concerns, or would like to request an extension. At this stage, your manuscript remains formally under active consideration at our journal; please notify us by email if you do not intend to submit a revision so that we may withdraw it. **IMPORTANT - SUBMITTING YOUR REVISION** Your revisions should address the specific points made by each reviewer. Please submit the following files along with your revised manuscript: 1. A 'Response to Reviewers' file - this should detail your responses to the editorial requests, present a point-by-point response to all of the reviewers' comments, and indicate the changes made to the manuscript. *NOTE: In your point-by-point response to the reviewers, please provide the full context of each review. Do not selectively quote paragraphs or sentences to reply to. The entire set of reviewer comments should be present in full and each specific point should be responded to individually, point by point. You should also cite any additional relevant literature that has been published since the original submission and mention any additional citations in your response. 2. In addition to a clean copy of the manuscript, please also upload a 'track-changes' version of your manuscript that specifies the edits made. This should be uploaded as a "Revised Article with Changes Highlighted" file type. 3. Resubmission Checklist When you are ready to resubmit your revised manuscript, please refer to this resubmission checklist: https://plos.io/Biology_Checklist To submit a revised version of your manuscript, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' where you will find your submission record. Please make sure to read the following important policies and guidelines while preparing your revision and fulfil the editorial requests: a) *PLOS Data Policy* Please note that as a condition of publication PLOS' data policy (http://journals.plos.org/plosbiology/s/data-availability) requires that you make available all data used to draw the conclusions arrived at in your manuscript. If you have not already done so, you must include any data used in your manuscript either in appropriate repositories, within the body of the manuscript, or as supporting information (N.B. this includes any numerical values that were used to generate graphs, histograms etc.). Please also indicate in each figure legend where the data can be found. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5 b) *Published Peer Review* Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details: https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/ c) *Blot and Gel Data Policy* Please provide the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare them now, if you have not already uploaded them. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements d) *Protocols deposition* To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments. Best wishes, Ines -- Ines Alvarez-Garcia, PhD Senior Editor PLOS Biology ialvarez-garcia@plos.org ------------------------------------ Reviewers' comments Rev. 1: The authors of this enlightening study have demonstrated that macrophages can perform self-generated gradient chemotaxis towards C5a, turning a flat concentration of C5a into a gradient, and then migrating up that gradient. They also showed that normal chemotaxis requires the same self-generated gradient. They confirmed that there is an optimal concentration of C5a. Experiments and analysis indicate that BMDMs use clathrin-mediated endocytosis for the C5a uptake. The paper is clearly written. Here is what can improve it: 1) the model was used for the initial result in fig 1, and was not applied to anything else in the paper. It could be useful, for example, to simulate the results of fig 3. 2) The 'wave of cell migration' is just a visual impression for now. it would be better to quantify this phenomenon and report quantitative measures. 3) It would be interesting to try to change the initial cell densities and measure responses, as well as simulating such experiments with the model. 4) Quantifying a response to not only the flat concentration of C5a but also to an initial gradient of C5a would be informative. Rev. 2: Phagocytes are guided to sites of inflammation by complement C3a and C5a, as well as other chemoattractants. It has been known for a long time that membrane-bound enzymes can degrade extracellular chemoattractants, such as cAMP (PDE expressed in Dictyostelium) (e.g. Sucgang et al., Dev. Biol. 1997) and complement C5a (carboxypeptidase M in immune cells) (e.g. Rehli et al. 1995; Krause et al., Immunol. Rev. 1998), and thereby reshape the chemoattractant gradient. However, both enzymatic degradation and receptor-mediated internalization of chemoattractants have emerged as functionally important mechanisms of self-generated gradients (e.g. Boldajipour et al., Cell 2007; Dona et al., Nature 2013; Tweedy et al., PloS Biol. 2016; Tweedy & Insall, Front. Cell Dev. Biol. 2020), allowing chemotaxis in the absence of an imposed gradient (i.e. in a uniform concentration) or enhancing directional migration in the presence of a defined concentration gradient. In this study, Kiran et al. nicely demonstrated that both mouse bone marrow-derived macrophages (BMDMs) and a human myeloid cell line (THP-1 cells) can self-generate a chemoattractant gradient, albeit using differents mechanisms. Using a fluorescent ligand, the authors could show that mouse BMDMs self-generate a gradient through complement C5a receptor 1 (C5aR1)-mediated complement C5a internalization. In contrast, THP-1 cells, but not BMDMs, degraded complement C5a through the activity of membrane-bound carboxypeptidase M (confirmed by mass spectrometry). Moreover, maximal cell density at the wave front of self-generated chemotaxis was observed at higher starting complement C5a concentrations, which could be explained by the higher rate of chemoattractant depletion by enzymatic activity compared to receptor-mediated internalization and receptor recycling. That is, mouse BMDMs, which lack the enzyme, are limited by receptor availability. The authors additionally showed, using BMDMs, that pretreatment with a Toll-like receptor 4 ligand, lipopolysacchardies (LPS), augmented chemotaxis. The experiments are well designed and the data nicely support the conclusions. This study advances the concept of self-generated gradients as a key element in chemotactic signaling and offers a framework to both interpret and predict the behavior of motile immune cells. Comments 1. The authors should discuss why THP-1 cells (human monocytic leukemia line) were used instead of, for example, human peripheral blood monocyte-derived macrophages. 2. Please discuss the differences in actin cytoskeletal dynamics in mouse BMDMs versus THP-1 cells. The former appear to have low rear end RhoA/actomyosin activity, whereas the latter exhibit a rounded morphology. 3. The authors should briefly discuss the potential roles of relay signals, such as auto- and paracrine Leukotriene B4 (LTB4) and ATP signaling in self-generated gradients and chemotaxis. Minor comments 1. New Figure 1: It would be helpful to include a new figure (Figure 1), which shows the Insall chamber in a schematic form. This will help explain the lateral gray-shaded structures in some of the figures and supplementary movies, e.g. Fig. 1C, and save the "busy reader" from looking up the original description of the chamber. 2. Abstract: The word "enzymatic" is perhaps superfluous in the text "through carboxypeptidase-mediated enzymatic degradation"? 3. Figure 1C: It would help the reader if "Self-generated gradient" was included in the label at the end of end panel. Otherwise, the "busy reader" needs to consult the legend. 4. The Methods section contains passages where the grammar and phrasing could be refined. Examples are highlighted below. 5. Methods: Cell culture - "The cells were stimulated with 10ng/ml of LPS experiment a day prior to the chemotaxis experiments" should be "The cells were stimulated with 10ng/ml of LPS [delete "experiment"] a day prior to the chemotaxis experiments" or similar. 6. Methods: Confocal microscopy - "Intensity measurement experiments were performed using Nikon A1R inverted and Zeiss confocal microscope equipped with motorized stage" should be "Intensity measurement experiments were performed using a [add "a"] Nikon A1R inverted and Zeiss confocal microscope equipped with motorized stage". 7. Methods: Confocal microscopy - "AlexaFluor-647®" should be "Alexa Fluor-647®" 8. Methods: Confocal microscopy - "Mouse and human C5as" should be "Mouse C5a and human C5a" 9. Methods: Confocal microscopy - "For intensity measurement experiment for SGG experiments shown in Figure 4" should be "For intensity measurements relating to SGG experiments shown in Figure 4" or similar. 10. Methods: Confocal microscopy - "10nM C5a-AF647® was added in the inner well with and without cells in the outer well of the chemotaxis chamber" should be "10nM C5a-AF647® was added to the inner well, either with or without cells in the outer well of the chemotaxis chamber" or similar ["to" instead of "in", and ", either with or without"]. 11. Methods: Confocal microscopy - "Image scanning was done with 633nm laser and images were acquired using 40X/1.3NA oil and 60X/1.4NA oil objective" should be "Image scanning was done with "a" 633nm laser and images were acquired using "either" a 40X/1.3NA oil or 60X/1.4NA oil objective". 12. Methods: Confocal microscopy - "The confocal imaging to evaluate the C5aR1 mediated uptake of C5a AF647® (Figure 6F) were performed using a 60x/1.4NA oil objective on a Nikon NSPARC and Zeiss 980" should be The confocal imaging to evaluate the C5aR1 mediated uptake of C5a-AF647® (Figure 6F) were performed using a 60x/1.4NA oil objective on "either" a Nikon NSPARC "or" Zeiss 980 "microscope""or similar. 13. Be consistent with C5a-AF647® - it also appears as C5a-AF647 or C5a AF647® in the manuscript. 14. Methods: Confocal microscopy - "For analysis, outline was made around all the cells, and their fluorescent intensity was measured" should be "For analysis, regions of interest were drawn around each cell, and their fluorescent intensity was measured" or similar. 15. Fig. 6 Legend: "student's t-test" should be "Student's t-test" [capital "S" and "t" in italics] 16. Legend of Movie 7: "10 µM PMX-53 everywhere" does not sound very scientific. Perhaps "10 µM PMX-53 (uniform throughout)" would be better. 17. The figure legends lack a consistent format. Some use "(A) … (B) …", while others do not. Please revise all figure legends to follow the journal's standardized style and ensure consistency throughout. |
| Revision 2 |
|
Dear Robert, Thank you for your patience while we considered your revised manuscript entitled "Macrophage chemotaxis steered by complex self-generated gradients of complement C5a" for publication as a Research Article at PLOS Biology. This revised version of your manuscript has been evaluated by the PLOS Biology editors, the Academic Editor and one of the original reviewers. Based on the review, we are likely to accept this manuscript for publication, provided you satisfactorily address the data and other policy-related requests stated below my signature. In addition, we would like you to consider a suggestion to improve the title: "Macrophages can self-generate complex gradients and enhance chemotaxis towards complement component 5a" As you address these items, please take this last chance to review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the cover letter that accompanies your revised manuscript. In addition to these revisions, you may need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests shortly. If you do not receive a separate email within a few days, please assume that checks have been completed, and no additional changes are required. We expect to receive your revised manuscript within two weeks. To submit your revision, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' to find your submission record. Your revised submission must include the following: - a cover letter that should detail your responses to any editorial requests, if applicable, and whether changes have been made to the reference list - a Response to Reviewers file that provides a detailed response to the reviewers' comments (if applicable, if not applicable please do not delete your existing 'Response to Reviewers' file.) - a track-changes file indicating any changes that you have made to the manuscript. NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines: https://journals.plos.org/plosbiology/s/supporting-information *Published Peer Review History* Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details: https://plos.org/published-peer-review-history/ *Press* Should you, your institution's press office or the journal office choose to press release your paper, please ensure you have opted out of Early Article Posting on the submission form. We ask that you notify us as soon as possible if you or your institution is planning to press release the article. *Protocols deposition* To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols Please do not hesitate to contact me should you have any questions. Best wishes, Ines -- Ines Alvarez-Garcia, PhD Senior Editor PLOS Biology ialvarez-garcia@plos.org ------------------------------------------------------------------------ DATA POLICY: You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: http://journals.plos.org/plosbiology/s/data-availability. For more information, please also see this editorial: http://dx.doi.org/10.1371/journal.pbio.1001797 Note that we do not require all raw data. Rather, we ask that all individual quantitative observations that underlie the data summarized in the figures and results of your paper be made available in one of the following forms: 1) Supplementary files (e.g., excel). Please ensure that all data files are uploaded as 'Supporting Information' and are invariably referred to (in the manuscript, figure legends, and the Description field when uploading your files) using the following format verbatim: S1 Data, S2 Data, etc. Multiple panels of a single or even several figures can be included as multiple sheets in one excel file that is saved using exactly the following convention: S1_Data.xlsx (using an underscore). 2) Deposition in a publicly available repository. Please also provide the accession code or a reviewer link so that we may view your data before publication. Regardless of the method selected, please ensure that you provide the individual numerical values that underlie the summary data displayed in the following figure panels as they are essential for readers to assess your analysis and to reproduce it: Fig. 1D; Fig. 3C; Fig. 4B; Fig. 5B, D-H and Fig. 6C, D, E, G NOTE: the numerical data provided should include all replicates AND the way in which the plotted mean and errors were derived (it should not present only the mean/average values). Please also ensure that figure legends in your manuscript include information on WHERE THE UNDERLYING DATA CAN BE FOUND, and ensure your supplemental data file/s has a legend. Please ensure that your Data Statement in the submission system accurately describes where your data can be found. ------------------------------------------------------------------------ CODE POLICY Per journal policy, if you have generated any custom code during the course of this investigation, please make it available without restrictions. Please ensure that the code is sufficiently well documented and reusable, and that your Data Statement in the Editorial Manager submission system accurately describes where your code can be found. More information on our Code Policy, what and how to share can be found here: https://journals.plos.org/plosbiology/s/code-availability Please note that we cannot accept sole deposition of code in GitHub, as this could be changed after publication. However, you can archive this version of your publicly available GitHub code to Zenodo. Once you do this, it will generate a DOI number, which you will need to provide in the Data Accessibility Statement (you are welcome to also provide the GitHub access information). See the process for doing this here: https://docs.github.com/en/repositories/archiving-a-github-repository/referencing-and-citing-content ------------------------------------------------------------------------ Reviewers' comments Rev. 1: The authors addressed all comments well. |
| Revision 3 |
|
Dear Robert, Thank you for the submission of your revised Research Article entitled "Macrophages Self-Generate And Refine Chemotactic Gradients During Migration Towards Complement C5a" for publication in PLOS Biology. On behalf of my colleagues and the Academic Editor, Sui Huang, I am delighted to let you know that we can in principle accept your manuscript for publication, provided you address any remaining formatting and reporting issues. These will be detailed in an email you should receive within 2-3 business days from our colleagues in the journal operations team; no action is required from you until then. Please note that we will not be able to formally accept your manuscript and schedule it for publication until you have completed any requested changes. Please take a minute to log into Editorial Manager at http://www.editorialmanager.com/pbiology/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production process. PRESS We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with biologypress@plos.org. If you have previously opted in to the early version process, we ask that you notify us immediately of any press plans so that we may opt out on your behalf. We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/. Many congratulations and thanks again for choosing PLOS Biology for publication and supporting Open Access publishing. We look forward to publishing your study. Sincerely, Ines -- Ines Alvarez-Garcia, PhD Senior Editor PLOS Biology ialvarez-garcia@plos.org |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .